Nektar Therapeutics · NASDAQ:NKTR
The Vanguard Group reported a 4.98% stake in Nektar Therapeutics (Schedule 13G/A)
Event Sep 30, 2025 · Filed Oct 31, 2025
The Vanguard Group reported a 4.98% stake in Nektar Therapeutics, 948,647 shares, as a passive investor on Sep 30, 2025. Filed Oct 31, 2025 (Schedule 13G/A).
- Stake
- 4.98%
- Shares
- 948,647
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 4.98% | 948,647 |
Source
Related
- Nektar Therapeutics
- The Vanguard Group
- Nektar Therapeutics shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G · The Vanguard Group · Jan 30, 2026
- Schedule 13G/A · Two Seas Capital LP · Sep 28, 2026
- Form 4 · Whitfield Roy A · Sep 25, 2026
- Form 4 · Greer R Scott · Sep 25, 2026
- Form 4 · Chess Robert · Sep 25, 2026
- Form 4 · Brainard Diana · Sep 25, 2026